The Uromigos

Episode 424: ASCO 2025 - Emergency podcast on the prostate rapid oral session 02.06.2025 30:10 ↓

Jorge Garcia joins us to discuss the process of selecting abstracts for oral presentation and select highlights from this session.

Episode 423: ASCO 2025 - Casdatifan plus Cabo in refractory RCC 01.06.2025 30:49 ↓

Toni Choueiri discusses this combination cohort of HIF inhibition plus VEGF-R inhibition.

Episode 422: ACSO 2025 - ctDNA data from NIAGARA 01.06.2025 32:40 ↓

Matt Galsky discusses the ASCO 2025 data regarding ctDNA from the NIAGARA neoadjuvant chemo +/- durvalumab study.

Episode 421: ASCO 2025 - Maintenance Avelumab +/- SG in Advanced Bladder Cancer 01.06.2025 34:49 ↓

Jeannie Hoffman-Censits discusses her randomized phase 2 adding SG to maintenence avelumab in mUC.

Episode 420: ASCO 2025 - CheckMate 901: Ipi/Nivo vs chemo for Cis-ineligible metastatic urothelial cancer 01.06.2025 24:18 ↓

Michiel Van Der Heijden joins us to discuss the Ipi/Nivo vs chemo randomization in this trial from his ASCO 2025 presentation

Episode 419: ASCO 2025 - Correlate data from the IMmotion 010 RCC adjuvant study 31.05.2025 23:49 ↓

Monty Pal discusses more correlates from this trial including matched baseline and progression tissue samples.

Episode 418: ASCO 2025 - Biomarkers in RCC 31.05.2025 44:55 ↓

David McDermott joins us on the heels of his outstanding discussion of the clinical science symposium on RCC biomarkers.

Episode 416: ASCO 2025 Preview 19.05.2025 40:43 ↓

Silke, Tom and Brian discuss what they are looking forward to at ASCO 2025

Episode 413: The Uromigos Score for Advanced Prostate Cancer 12.05.2025 37:02 ↓

Silke and Chris joins us to discuss our latest 'Uromigos Score' in which experts score the value of treatments for advanced prostate cancer. Several interesting themes emerge.

Episode 410: AUA 2025 - BOND-003 Cohort C: Cretostimogene in BCG-Unresponsive NMIBC 05.05.2025 28:52 ↓

Mark Tyson from Mayo Clinic joins the podcast to discuss this replicating adenovirus and a high CR rate in BCG-unresponsive NMIBC

Episode 412: AUA 2025 - TAR-200 Monotherapy in BCG-Unresponsive NMUIBC from SunRISe-1 05.05.2025 37:20 ↓

Joe Jacob joins the show to discuss the longer-term follow up of this cohort from SunRISe-1. We discuss definitions of CR and regulatory issues around drug approval in this space as well.

Episode 411: Live from EIKCS in Amsterdam - RCC Highlights 03.05.2025 20:26 ↓

Viktor Grunwald joins to discuss the new data session from EIKCS

Episode 409: AUA 2025 - CREST - BCG +/- Sasanlimab in high-risk NMIBC 26.04.2025 47:27 ↓

Neal Shore joins the show to discuss these exciting data from the American Urological Association Annual Meeting

Episode 407: Drug Development in China: Part 2 of 2 21.04.2025 25:21 ↓

Part 2 of our series dives deeper into the explosion of ADC clinical drug development in China

Episode 406: Drug Development in China: Part 1 of 2 14.04.2025 30:02 ↓

Drs. Dingwei Ye and Yao Zhu from China join the show to talk about drug development in China amid the recent surge of GU clinical trials.

Episode 405: The Good News About Cancer podcast 11.04.2025 17:53 ↓

Drs. Alicia Morgans and Chuck Ryan join the show to talk about their new podcast.

Episode 404: 177 Lu-PSMA Pre-chemotherapy in mCRPC. Final Podcast from the Canary Islands 07.04.2025 27:09 ↓

Elena Castro joins Tom and Brian on the day after Pluvicto approval pre-chemotherapy in the US to discuss the PSMA Fore data and application in clinical practice.

Episode 403: ADCs in Bladder Cancer. Part 2 from the Canary Islands 02.04.2025 37:41 ↓

Ignacio Duran continues his discussion with Brian and Tom regarding novel ADCS in bladder cancer

Episode 401: ADCs in Bladder Cancer. Part 1 from the Canary Islands 29.03.2025 30:29 ↓

Ignacio Duran joins the show to discuss the landscape of established ADCs in urothelial cancer and challenges of drug development in this setting.

Episode 400: The Uromigos Score for Urothelial Cancer 28.03.2025 20:19 ↓

Live from the Canary Islands 'Big Idea' talk from Tom, we discuss the new Uromigos Score which ranks different treatment options in several urothelial cancer settings.

Episode 399: A PD1/VEGF Bispecific in Lung Cancer - Lessons for GU Cancers? 24.03.2025 36:44 ↓

Dr. John Heymach from MD Andersons joins us to discuss a novel PD1/VEGF bispecific agent in lung cancer and if there are applicaitons in GU malignancies.

Episode 398: Reflections on the Felix Feng Symposium at ASCO GU 17.03.2025 32:05 ↓

Chuck Ryan joins us to discuss his interview with Felix and reflects on his keynote address at ASCO GU 2025.

Episode 397: APCCC Diagnostics Conference recap 10.03.2025 43:15 ↓

Silke Gillessen joins us to discuss the top areas of consensus and controversy from APCCC 2025

Episode 394: APCCC (Advanced Prostate Cancer Consensus Conference) Diagnostics 2025 01.03.2025 30:27 ↓

Tyler Seibert from UCSD joins the show live from Lugano to discuss meeting highlights and controversies (and his favorite run along the water..)

Episode 393: ASCO GU 2025 Review Podcast 26.02.2025 46:06 ↓

Silke joins Tom and Brian to discuss highlights form ASCO GU 2025